戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 aid in identifying subtypes more amenable to immunomodulation.
2 anisms: malignant cell killing and TAM-based immunomodulation.
3  variety of homeostatic functions, including immunomodulation.
4 imates in the setting of clinically relevant immunomodulation.
5  scale that provides new insights into viral immunomodulation.
6 the level of these antibodies was lowered by immunomodulation.
7 genesis of severe pneumonia and a target for immunomodulation.
8 SHED-mediated osteogenic differentiation and immunomodulation.
9  19 genes associated with tissue tropism and immunomodulation.
10 ng cytokine partial agonists for therapeutic immunomodulation.
11 esent therapeutic targets for anti-CD132 mAb immunomodulation.
12 otential as an easily modifiable mediator of immunomodulation.
13 lecule has been shown to provide therapeutic immunomodulation.
14 nt, with further evidence of strain-specific immunomodulation.
15  for antimetabolite or calcineurin inhibitor immunomodulation.
16 te fungal killing and also provide effective immunomodulation.
17 cellular differentiation, proliferation, and immunomodulation.
18 onse and a PD-L1-dependent allogeneic-driven immunomodulation.
19 tion for the purpose of cancer treatment and immunomodulation.
20 ive approach to upregulate Tregs and achieve immunomodulation.
21 nocytes play an important role in MSC driven immunomodulation.
22 pressor cells primarily implicated in cancer immunomodulation.
23 promising target for small molecule-directed immunomodulation.
24  with the immune system and how they mediate immunomodulation.
25 ific biomarker for type 1 diabetes onset and immunomodulation.
26 further characterising the effects of FOs on immunomodulation.
27 o inform new therapeutic strategies based on immunomodulation.
28 that depletes lymphocytes, causing long-term immunomodulation.
29 regulation and suggest unique strategies for immunomodulation.
30  Polysaccharide and lipid components promote immunomodulation.
31 is via targeted depletion of macrophages and immunomodulation.
32 or the role of glucocorticoids in MW-induced immunomodulation.
33 rammed has led to paradigm-shifting views on immunomodulation.
34 s, and massive lymphocyte apoptosis prevents immunomodulation.
35  use in T cells may reveal novel targets for immunomodulation.
36  as a novel potential target for therapeutic immunomodulation.
37 ted to provide therapeutic immunosuppression/immunomodulation.
38 velopment and, in some parasitic species, in immunomodulation.
39 utinin (FHA) that functions in adherence and immunomodulation.
40 apeutic approach to achieve antigen-specific immunomodulation.
41 ing that A35 increases poxvirus virulence by immunomodulation.
42 metabolic diseases as well as for cancer and immunomodulation.
43  present potential pharmacologic targets for immunomodulation.
44  Cell Death 1 (PD-1) plays a crucial role in immunomodulation.
45 al design will potentially expand to include immunomodulation.
46 constituting a unique target for therapeutic immunomodulation.
47 ue regeneration may, in reality, result from immunomodulation.
48 eceptor modulation in lungs is essential for immunomodulation.
49 t disease (TA-GVHD), and transfusion-induced immunomodulation.
50 in mice, associated with mucosal healing and immunomodulation.
51 bute to eosinophil-mediated inflammation and immunomodulation.
52 f Lck could be a useful adjunct for enhanced immunomodulation.
53 hat the beneficial effect of NECA was due to immunomodulation.
54  as well as efforts to engineer peptides for immunomodulation.
55 he T cell may represent a useful approach to immunomodulation.
56  provide a new strategy for HIV therapies or immunomodulation.
57 ssion of genes important in host defense and immunomodulation.
58  with focused activity that permit selective immunomodulation.
59 TNF-alpha play crucial roles in MSC-mediated immunomodulation.
60  many genes with roles in carcinogenesis and immunomodulation.
61 ing pathogen uptake, antigen processing, and immunomodulation.
62 whereas the CD56bright subset is involved in immunomodulation.
63 ify TGF-beta2 as the crucial mediator of NPC immunomodulation.
64 host organelles, many of which have roles in immunomodulation.
65 e, they are valuable therapeutic targets for immunomodulation.
66 nant proteins to study their contribution to immunomodulation.
67 VEM function during HSV infection: entry and immunomodulation.
68 e function of Treg in the CNS, distinct from immunomodulation.
69  enzyme inhibition, antioxidant, opioid, and immunomodulation.
70 efficacy may be affected by parasite-induced immunomodulation.
71 cytostatics, the molecular mechanisms of its immunomodulation ability have not been investigated thor
72         Mesenchymal stem cell (MSC)-mediated immunomodulation affects both innate and adaptive immune
73 gate the responses of hPDL cells in terms of immunomodulation after TLR3 engagement.
74                                              Immunomodulation aimed at maximizing the beneficial effe
75 ell as a translational research platform for immunomodulation and advanced organ bioengineering.
76           Finally, RNS60 treatment exhibited immunomodulation and ameliorated adoptive transfer of ex
77  The pleiotropic effects of statins, such as immunomodulation and anti-inflammatory effects, may also
78 IFN-alpha, an antiviral cytokine involved in immunomodulation and control of HIV type 1 replication,
79 R2 by Bryo-1 has significant implications in immunomodulation and could overcome some of the immune d
80 hMSC) and mouse mesenchymal stem cell (mMSC) immunomodulation and differentiation, depending on the i
81 ns for improved lung remodeling and for dual immunomodulation and direct microbial kill-based treatme
82 me in modulating host health with a focus on immunomodulation and discusses strategies for manipulati
83 yltryptophan conjugates 1 and 2 for combined immunomodulation and DNA cross-link-triggered apoptosis
84 d survival but also facilitate tumor-induced immunomodulation and eventual metastasis.
85 n disease pathogenesis, contributing to both immunomodulation and host tissue injury.
86 Therapeutic approaches predominantly involve immunomodulation and immunosuppression and are targeted
87 may identify breast cancers more amenable to immunomodulation and indicate additional strategies to e
88 repair through mechanisms that involved both immunomodulation and induction of neurotrophic factors.
89  effect of vitamin D on lung development and immunomodulation and present the evidence of its role in
90  are relevant to depression: synaptogenesis, immunomodulation and regulation of glycogen synthase kin
91          Up to 20% of patients relapse after immunomodulation and require additional treatment.
92 nt clinical significance in helminth-induced immunomodulation and sepsis.
93 d the molecular mechanisms underpinning such immunomodulation and show here that ES-62-mediated downr
94  and cancer, applied to immune surveillance, immunomodulation and the functions of IgE-mediated immun
95 lso discussed as a potential drug target for immunomodulation and the treatment of leukemia.
96 an primates point to a broader role for PD-1 immunomodulation and to potential applications in humans
97                               The pattern of immunomodulation and transcriptional dysregulation induc
98 hese findings identify potential targets for immunomodulation and treatment to combat lethal WNV infe
99 cle regeneration by providing stage-specific immunomodulation and trophic and mechanical support.
100 atients failed to convert with pretransplant immunomodulation and were not transplanted; 51 underwent
101 ent a new class of targeted therapeutics for immunomodulation and/or cancer therapy.
102 s, including attachment to epithelial cells, immunomodulation, and competitive exclusion of pathogens
103 bial activity, anticancer, hepatoprotection, immunomodulation, and improving skin health and digestiv
104 e been linked to glioma invasive properties, immunomodulation, and increased angiogenesis, leading to
105 e engineering: multilineage differentiation, immunomodulation, and production of trophic factors.
106  approaches to find a better adjuvant, focus immunomodulation, and reduce allergenicity are under inv
107 on the skin include tanning, carcinogenesis, immunomodulation, and synthesis of vitamin D, among othe
108 -C, whose presentation is resistant to viral immunomodulation, and well-studied HLA-B-restricted epit
109 ence, treatment strategies that are based on immunomodulation are on the rise.
110 n, the development of cancer stem cells, and immunomodulation are plausible underlying mechanisms by
111 ts, the molecular mechanisms underlying this immunomodulation are poorly characterized.
112 eir in vivo efficacy and persistence by host immunomodulation are presented in the context of an ever
113 macaques infected without the need for prior immunomodulation as is required for some other models.
114 ediate hemadsorption and be involved in host immunomodulation as well as the induction of protective
115  in gene and drug delivery, diagnostics, and immunomodulation, as well as on the utility of nanoflare
116 4 and RL12/RL13/UL1 loci for virus entry and immunomodulation, but not between genes more distant fro
117 rly childhood and aids in food digestion and immunomodulation, but the mechanisms driving its develop
118 ing to anergy and apoptosis; however, active immunomodulation by accumulating tryptophan catabolites,
119               These findings reveal profound immunomodulation by bordetellae and demonstrate that by
120  expression in M-MDSCs accounts for positive immunomodulation by chemotherapeutic agents.
121 rphogenesis, with potential implications for immunomodulation by HCMV, and may also be a mechanism by
122 an important, often overlooked, mechanism of immunomodulation by PUFAs.
123                                              Immunomodulation by Siglecs has been extensively studied
124 C-mediated molecular mechanism that triggers immunomodulation by targeting Kv1.3 in leukocytes.
125 hese data establish a mechanism for systemic immunomodulation by the microbiota and highlight potenti
126 o our understanding of the mechanisms behind immunomodulation by the RRV vIRFs during infection.
127 esis and emergence from latency, elucidating immunomodulation by this medically important cohort of v
128 f the role of carbohydrates in infection and immunomodulation by this significant protozoan parasite.
129  survival of the parasites, helminth-induced immunomodulation can also have a number of benefits for
130 antitumor immune effectors elicited by local immunomodulation can eradicate tumor cells at distant si
131 tiviral and antimicrobial defense, including immunomodulation, cell cycle regulation, cell survival,
132 and evaluated mechanisms by which beneficial immunomodulation could occur in this system.
133 proteins, which are therefore treatable with immunomodulation, could account for some cases of idiopa
134 lation maintained, and a mechanism for S1PR1 immunomodulation described.
135                                              Immunomodulation (desensitization) protocols may reduce
136 rednisolone on microvascular dysfunction and immunomodulation during IRI in rat cardiac allografts su
137 r perioperative TPE are typically related to immunomodulation during solid-organ transplant.
138 nological adjuvants were incorporated, their immunomodulation effect for cytokine TNF-alpha and IL-6
139 myelitis (EAE) model and observed pronounced immunomodulation evident by a reduction in pro-inflammat
140 es to prevent viral infections, based on the immunomodulation faces many problems related to the ecto
141 es, thus pointing towards a new direction of immunomodulation for SCI repair.
142 he potential usefulness of parasite-mediated immunomodulation for the treatment and prevention of a r
143 ition and osteoclastic tissue resorption and immunomodulation for tissue development.
144                                              Immunomodulation had no impact on the amount of cardiac
145 d Clinical Immunology Task Force on Diet and Immunomodulation has systematically explored the associa
146 t, gene-directed enzyme prodrug therapy, and immunomodulation have been recently investigated with po
147 studies pointed to a functional link between immunomodulation, histamine production, and folate metab
148  measles infection results in a 2- to 3-year immunomodulation, implicating measles in substantially m
149 hocytes as a novel approach for T lymphocyte immunomodulation in autoimmune diseases without affectin
150  widely regarded as a therapeutic target for immunomodulation in autoimmune diseases.
151 These results reveal a vital role for TNC in immunomodulation in brain tumor biology and demonstrate
152  warranting further investigation of CD81 in immunomodulation in cancer and its progression.
153 s of MDSCs and may be a potential target for immunomodulation in conjunction with antiviral therapy d
154  NF-kappaB pathway as a potential target for immunomodulation in HAM/TSP.
155 ever, the mechanisms of maraviroc-associated immunomodulation in human immunodeficiency virus (HIV)-i
156  the JNK pathway are involved in LPS-trained immunomodulation in MSCs.
157         For studies that explore therapeutic immunomodulation in multiple sclerosis, rigorous monitor
158 ropathy, and scleritis in patients requiring immunomodulation in patients who have failed or who are
159 kely to be a "one size fits all" approach to immunomodulation in patients with COVID-19. We believe t
160                                  Testing for immunomodulation in PBMC cells shows the induction of th
161            CDK9 activity may be a target for immunomodulation in RSV-induced lung disease.
162 ttributed with morphological deformities and immunomodulation in susceptible regions of the depressed
163 dies underscore the complex nature of PGE(2) immunomodulation in the context of host-microbial intera
164                 While local microbial-driven immunomodulation in the gut is well described, more rece
165 tral role in inflammation, fibrogenesis, and immunomodulation in the HCC microenvironment.
166 high-fat diet to induce obesity and to study immunomodulation in the intestine.
167 ying the therapeutic effects of NSCs include immunomodulation in the periphery and the central nervou
168 ose that not only are microbiota targets for immunomodulation in this disease, but also that microbio
169 tion may be a viable approach to therapeutic immunomodulation in this disease.
170 elta1 ligand as a potential novel target for immunomodulation in transplantation.
171                       Cellular therapies for immunomodulation in vascularized composite allotransplan
172  In this study, we studied whether concerted immunomodulation in vivo by CTLA4Ig depends on IDO.
173 mpact of vFcgammaRs on HCMV pathogenesis and immunomodulation in vivo is not known.
174 g a possible mechanism for galectin-mediated immunomodulation in vivo.
175                                              Immunomodulation, in particular improvement of the host
176 ortant roles in defense, microbial adhesion, immunomodulation, inflammation, and cancer.
177                           Here, we report an immunomodulation involving the Bordetella bronchiseptica
178 at a large amount of work on MGBA focused on immunomodulation, irritable bowel syndrome, and neurodev
179                                              Immunomodulation is a common feature of chronic helminth
180                                              Immunomodulation is a key function of the microbiome and
181                                              Immunomodulation is a promising strategy in anticancer t
182                  Prophylactic or therapeutic immunomodulation is an antigen-independent strategy that
183                                              Immunomodulation is emerging as an effective means of sh
184                              Sustained viral immunomodulation is implicated in a variety of inflammat
185  vertebrate immunity, we also show that host immunomodulation is implicated in the deleterious phenot
186 essional antigen-presenting cells respond to immunomodulation is important for both new innate and ad
187 ny of the studies concluded that BMSC-driven immunomodulation is mediated by the suppression of proin
188                                           As immunomodulation is not devoid of deleterious side effec
189                              Evasion through immunomodulation is one of the several strategies adopte
190                             Helminth-induced immunomodulation is thought to influence the outcome of
191 tivate TLR2-signaling and that TLR2-mediated immunomodulation is unlikely to play a significant role
192                  Furthermore, serial in situ immunomodulation (ISIM) reshapes repertoires of intratum
193 ive development of numerous biomaterials for immunomodulation, it is only recently that an experiment
194 re, we identified another mechanism of BILF1 immunomodulation: it targets newly synthesized MHC-I/pep
195 cination argues that neutralization of viral immunomodulation may be a new vaccine paradigm for HCMV
196 nsive evidence suggests that this innovative immunomodulation may be a safe approach to ameliorate al
197      Manipulation of Tregs or other types of immunomodulation may become a part of AML treatment in t
198 echanisms underlying stress effects on fetal immunomodulation may differ based on maternal atopic sta
199                                 Non-specific immunomodulation may have a role as a potential treatmen
200                 Results suggest that chronic immunomodulation may prevent recurrent optic neuritis an
201 he surgical patient, yet transfusion-related immunomodulation may underlie the association of allogen
202  CD8(+) effector response and reducing local immunomodulation mediated by CD8(+) regulatory T cells.
203     This demonstrates that clinically useful immunomodulation mediated by the S1P(1) receptor can be
204 rol and animal survival were associated with immunomodulation mediated by these 2 agents, which were
205      We therefore tested the hypothesis that immunomodulation might counteract this pathophysiologica
206 n (ILDKT) across HLA/ABO barriers, but added immunomodulation might put patients at increased risk of
207 will require a combination of strategies for immunomodulation, neuroprotection, and myelin replacemen
208                    Overall, helminth-related immunomodulation observed in MS patients was mediated by
209    These data indicate that helminth-induced immunomodulation occurs independently of changes in the
210 Grass pollen-specific immunotherapy involves immunomodulation of allergen-specific T(H)2 responses an
211 ation of various cellular pathways including immunomodulation of cancers and regulation of pancreatic
212 population may play an important role in the immunomodulation of CL.
213 fects of IVIG therapy can be mediated by the immunomodulation of DCs, creating a bridge that induces
214                                              Immunomodulation of distinct monocyte subsets has recent
215                                              Immunomodulation of FcgammaRIIb in clinical transplantat
216 g inflammation during AAA formation and that immunomodulation of IL-17 by MSCs can offer protection a
217  the current study was to explore whether an immunomodulation of infant responses could enhance prote
218 minating bacteria without lysis coupled with immunomodulation of inflammation should be pursued clini
219 model to address the potential mechanisms of immunomodulation of liver disease by creating two unique
220 ies in different tumor models revealed broad immunomodulation of lymphoid and myeloid cells by ADC an
221                                              Immunomodulation of macrophages against cancer has emerg
222 iming affinity and have implications for the immunomodulation of pathogenic T cell responses during t
223  on CD4(+) T cells have implications for the immunomodulation of pathologic T cell responses during t
224 y studies are showing promising results with immunomodulation of response to injury.
225  support an important role for infection and immunomodulation of T cells in clinical human disease.
226 link targeted immune cells with the elicited immunomodulation of T cells.
227 success as parasites is the result of active immunomodulation of the host immune response, which can
228        Together, these results indicate that immunomodulation of the host response may be an alternat
229 l cells, inhibition of bacterial growth, and immunomodulation of the host.
230 1 receptor can benefit from augmentation and immunomodulation of the immune response.
231 e parasites' success is the result of active immunomodulation of their hosts' immune response.
232 f therapeutic vaccination combined with such immunomodulation offers an attractive avenue for the dev
233 , we investigated the effect of prophylactic immunomodulation on the outcome of influenza virus infec
234  crucial component influencing regeneration, immunomodulation or immuno-engineering has emerged as a
235 r disease amelioration is due to nonspecific immunomodulation or mediated by Ag-specific regulation o
236  linked to inflammation, but whether altered immunomodulation plays a causative role in neurodegenera
237                                              Immunomodulation, primarily with immunosuppressive medic
238 fection is virus specific and is modified by immunomodulation prior to inoculation.
239 ymptomatic phase of the infection, different immunomodulation profiles were associated with DENV, WNV
240  and mechanistic basis for H. pylori-induced immunomodulation, promoting persistent infection and con
241 unctions, including intercellular signaling, immunomodulation, protein maturation and processing, met
242  tissues, although its potential function in immunomodulation remains to be explored.
243                                              Immunomodulation represents a novel approach to antimicr
244 Our data indicate that this novel concept of immunomodulation represents a safer method to reduce all
245       Here we demonstrate that PSA-dependent immunomodulation requires the Toll-like receptor (TLR) 2
246                           This SHED-mediated immunomodulation rescues OVX-induced impairment of bone
247            Concurrent with bleed management, immunomodulation should be initiated with corticosteroid
248 emically applied IL-22 did not display acute immunomodulation/stimulation in otherwise untreated or e
249                            Biomaterial-based immunomodulation strategies can significantly ameliorate
250  undesirable response, we compared transient immunomodulation strategies.
251 administration of 6-TG and allopurinol as an immunomodulation strategy in inflammatory disorders.
252              This study provides an accurate immunomodulation strategy that achieves safe and effecti
253 ets serves as a practical means of localized immunomodulation that accomplishes sustained graft survi
254 dentification of potential novel targets for immunomodulation that can be exploited therapeutically.
255 ved in the clearance of B. parapertussis and immunomodulation that delays effective clearance.
256  not generally achieved by the same level of immunomodulation that is capable of inducing tolerance o
257 ole for dysfunctional tissue repair in local immunomodulation that may have particular relevance to t
258 onalized, immunophenotype-driven approach to immunomodulation that may include anti-cytokine therapy
259                                   After this immunomodulation, the DBA/2 mice were given a high-phosp
260 mRNA and protein and demonstrated a targeted immunomodulation therapeutic effect ex vivo and in vivo,
261 trolled study of a device-based non-specific immunomodulation therapy (IMT) in patients with New York
262                                     Although immunomodulation therapy is promising, currently most of
263 tional thiopurines with or without following immunomodulation (thiopurine-allopurinol, biologicals, m
264                                  Amenable to immunomodulation, this interface is a unique target for
265 ndicates that for IgE-mediated food allergy, immunomodulation through food immunotherapy is possible;
266                          Cladribine provides immunomodulation through selective targeting of lymphocy
267 ut that future studies in humans may require immunomodulation to achieve long-term expression.
268 nders this molecule an attractive target for immunomodulation to achieve tolerance to auto- and trans
269 hasone, and support the value of therapeutic immunomodulation to delay the progression to multiple my
270 ntibody responses, suggesting that transient immunomodulation to disrupt B/T-cell interaction at the
271                                              Immunomodulation to enhance systemic and local responses
272 pplemental strategies such as vaccination or immunomodulation to facilitate their persistence.
273 d should provide targets for neuroprotective immunomodulation to treat these devastating neurodegener
274                                          For immunomodulation toward tolerance, food compounds could
275 u ammonis 1-3, and dentate gyrus) targets of immunomodulation-treated LGI1 VGKC-complex antibody-medi
276 nfluenza A/PR/8/34 virus 24 h after the last immunomodulation treatment and either monitored for surv
277 nt, underscoring the necessity to probe HCMV immunomodulation using specific T cells.
278 ugh the appropriate targets for intratumoral immunomodulation using this strategy are not known.
279 tivation of interleukin 1beta (IL-1beta) and immunomodulation via MyD88, the first signaling molecule
280 ed this agent could provide a novel route of immunomodulation via targeted inhibition of antigen-indu
281 endritic cells in tick-mediated Th1/Th2-cell immunomodulation was assessed.
282 e contribution of the purinergic mediator to immunomodulation was confirmed by exposing in vitro diff
283           This effect was mediated mainly by immunomodulation, which led to lower macrophage infiltra
284  interferon (IFN-gamma) production suggested immunomodulation, which was not restricted to parasite-s
285                                 This in situ immunomodulation, which was performed with low doses of
286       Novel therapeutic strategies including immunomodulation with agents like cyclosporine and angio
287                                              Immunomodulation with allogeneic cells rapidly and effic
288   These findings highlight that intratumoral immunomodulation with an oncolytic virus expressing a ra
289  some residual lesions after steroid use and immunomodulation with associated clinical recovery in pa
290 tion for MS, because it combines features of immunomodulation with beneficial effects on neuroregener
291                                              Immunomodulation with CsA reduces the expression of cyto
292                                              Immunomodulation with cyclosporine combined with antiret
293                                      In situ immunomodulation with Flt3L, radiotherapy, and TLR3/CD40
294                                              Immunomodulation with genetically modified cells express
295  are to achieve safe and effective long-term immunomodulation with neuroprotection and repair.
296 ating tumor progression through intratumoral immunomodulation, with broad implications in developing
297              hRetn promoted helminth-induced immunomodulation, with increased survival of Nippostrong
298                    Current therapies involve immunomodulation, with limited effects on neuronal damag
299 ing mechanisms in therapeutic resistance and immunomodulation within the tumor microenvironment.
300  in several organs with pleiotropic roles in immunomodulation, wound healing, and cell growth.

 
Page Top